 |
alectinib |
|---|---|
| Trade Name | Alecensa |
| Orphan Indication | Non-small cell lung cancer |
| USA Market Approval | USA |
| USA Designation Date | 2015-01-27 00:00:00 |
| Sponsor | Hoffmann-La Roche, Inc. (c/o Genentech, Inc.);1 DNA Way, MS #355E;South San Francisco, California, 94080 |
Related Access Program